Results 151 to 160 of about 233,338 (314)
Breast cancer progression in the presence of treated and untreated left ventricular dysfunction. [PDF]
Civati C +7 more
europepmc +1 more source
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis–related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang +6 more
wiley +1 more source
Forecasting left ventricular systolic dysfunction in heart failure with artificial intelligence [PDF]
Payal Chandak +7 more
openalex +1 more source
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean +4 more
wiley +1 more source
Association of PREVENT risk model with body fat distribution and subclinical left ventricular dysfunction. [PDF]
Hirose K +14 more
europepmc +1 more source
A 1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction [PDF]
Hajime Funakoshi +11 more
openalex +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Biological aging, left ventricular dysfunction and mortality in patients with heart failure with preserved ejection fraction. [PDF]
Xu X +11 more
europepmc +1 more source

